{"chebi_id":"45409","chebi_name":"ritonavir","chebi_synonyms":["N-[(2S,4S,5S)-4-hydroxy-1,6-diphenyl-5-{[(1,3-thiazol-5-ylmethoxy)carbonyl]amino}hexan-2-yl]-N2-(methyl{[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl}carbamoyl)-L-valinamide"],"diffprof_id_observed":["MTBLS2871_0002_00000009"],"diffprof_id_var_observed":["MTBLS2871_0002_00000009"],"inchikey":"NCDNCNXCDXHOMX-XGKFQTDJSA-N","inn_name":"ritonavir","iupac_name":"<em>N</em>-[(2<i>S</i>,4<i>S</i>,5<i>S</i>)-4-hydroxy-1,6-diphenyl-5-{[(1,3-thiazol-5-ylmethoxy)carbonyl]amino}hexan-2-yl]-<em>N</em><small><sup>2</small></sup>-(methyl{[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl}carbamoyl)-<small>L</small>-valinamide","num_study_observed":1,"reactome_ids":["R-HSA-1430728","R-HSA-211859","R-HSA-211945"],"reactome_names":["Metabolism","Biological oxidations","Phase I - Functionalization of compounds"],"study_id_observed":["MTBLS2871"],"study_id_var_observed":["MTBLS2871"],"synonym_name":""}